AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Vistin Pharma

Report Publication Announcement Oct 24, 2025

3782_rns_2025-10-24_2c9f695d-4f0c-4948-9780-a540f06d0ed6.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Vistin Pharma ASA: Invitation to Q3 2025 conference call

Vistin Pharma ASA: Invitation to Q3 2025 conference call

Oslo, Norway, 24 October 2025

Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2025 results on

Friday 31st of October 2025. Vistin Pharma will host a conference call for all

shareholders and interested parties on the same day at 08:30 CET. There will be

a Q&A session following the management discussion.

The conference call will be held in English.

The third quarter conference call will be available via web and audio through

the following access points:

Webcast: https://edge.media-server.com/mmc/p/zojifvb6

(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media-

server.com%2Fmmc%2Fp%2Fzojifvb6&data=05%7C02%7CAlexander.Karlsen%40vistin.com%7C

a4f762044c9844b78b6f08ddf42aab61%7C2fcdf060b2c2456e8bb7944b7e40981a%7C0%7C0%7C63

8935186643331816%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDA

wMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=W6bnr0E

m%2FU288%2BJ%2FzLaF42vyGP%2FdMZE2fvdYMjPFMQ4%3D&reserved=0)

Telephone conference (online registration):

https://register-conf.media-

server.com/register/BI4b6411bcd117427f8df81e59f7b2fd65

(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fregister-

conf.media-

server.com%2Fregister%2FBI4b6411bcd117427f8df81e59f7b2fd65&data=05%7C02%7CAlexan

der.Karlsen%40vistin.com%7Ca4f762044c9844b78b6f08ddf42aab61%7C2fcdf060b2c2456e8b

b7944b7e40981a%7C0%7C0%7C638935186643348798%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1h

cGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D

%7C0%7C%7C%7C&sdata=JaK5TpCz%2BwnMxRzZu7w%2Bg9xb3BtiG5G55gOVuohROwo%3D&reserved=

0)

*****

For further information, please contact:

Alexander Karlsen

CFO

+47 97053621

[email protected]

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin

Hydrochloride (API). The Metformin is also available as Direct Compressible

lubricated granules. As a solely dedicated European Metformin producer, Vistin

Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin

Pharma is headquartered in Oslo, Norway, and has highly qualified employees and

a dedicated manufacturing facility in Kragerø.

Talk to a Data Expert

Have a question? We'll get back to you promptly.